ENTITY

Merck KGaA (MRK GR)

42
Analysis
Health Care • Germany
Merck KGaA is a global pharmaceutical and chemicals company. The Company researches drugs in the areas oncology and neurodegenerative as well as autoimmune and inflammatory diseases. Also, it markets cardiovascular, fertility, endocrinology, and over-the-counter products as well as products for flat screens and the pharmaceutical, food, cosmetics, packaging, and coatings.
more
bullish•Versum Materials
•01 Mar 2019 00:28

Versum Materials – Entegris Beaten to the Punch by Merck KGaA

Merck KGaA (MRK GY), the German pharmaceutical and chemical company, gatecrashed the Entegris Inc (ENTG US) merger with Versum Materials (VSM...

Logo
834 Views
Share
bearish•MSCI ACWI Index
•20 Dec 2018 22:08

Global Markets Deteriorating...Except EM

With U.S. markets stumbling, the MSCI ACWI index is breaking down to new lows: defensive Sectors remain attractive. Relative to MSCI ACWI however,...

Logo
1k Views
Share
bearish•MSCI World Index
•15 Nov 2018 21:39

Global Markets Outlook: Maintain Defensive Posture

Our outlook for global equity markets remains cautious and we expect additional weakness and consolidation, notwithstanding shorter-term...

Logo
684 Views
Share
bearish•MSCI ACWI Index
•24 Oct 2018 06:02

Global Equity Strategy: Market Deterioration Continues; Cyclical & Growth Sectors Breaking Down

In our October International Strategy, we provide a synopsis on current market conditions around the globe, and explore the following themes in...

Logo
507 Views
Share
bullish•MSCI ACWI Index
•07 Sep 2018 20:32

Bottoms-Up View on Developed Markets: Actionable Stocks, Part 2

Our outlook remains neutral for global ex-U.S. markets while horizontal consolidation continues on the MSCI ACWI ex-U.S. index.  In today’s report...

Logo
559 Views
Share
x